The separated tumour cells as removed from the gradients were viable, and could be analysed by in vitro and in vivo assays. The separation procedure did not affect the expression by the tumour cells of TATAs and H-2 antigens. Furthermore, the method seemed to be applicable to the separation of human tumour cells from mononuclear cells prepared from blood samples of tumour patients by Ficoll centrifugation.
METASTASIZING TUMOUR CELLS from different organs have been compared to tumour cells from the respective primary tumour by several authors (Sugarbaker & Cohen, 1972; Deichman & Kluchareva, 1966; Fogel et al., 1977) . In these studies, time-consuming in vivo or in vitro culture methods were used to amplify the organderived tumour cells. During these amplification procedures the uncontrolled outgrowth of minorities in the cell populations could have changed the behaviour of the population originally existing in the organ.
With these methods, some authors showed similarities, others found differences between the surface markers of tumour cells from the primary tumour and those from the organs. Therefore, we tried to develop a quick method for the direct separation and isolation of metastasizing tumour cells from different organs in the mouse.
Previously it had been found that cell types of different origin (Akerstrom et al., 1979) , as well as cell organelles, possess unique densities (Price et al., 1979) . Such density differences could be used to separate cell subpopulations (Gutierrez et al., 1979; Kurnick et al., 1979) and subcellular components in animals and man (Jenkins et al., 1979 (Bosslet et al., 1979) .
The tumour-cell-lines or clones derived from them were propagated in vivo by i.p. transfer or in vitro by continuous passaging in culture medium as described previously by Schirrmacher et al. (1979a,b) and Schirrmacher & Bosslet (1980 The tubes were centrifuged at 2000 rev/min for 10 min in the Model TJ-8 centrifuge without use of the brake. In the case of unlabelled material, the visible bands of host cells or tumour cells were removed from the gradients with Pasteur pipettes. The cells were washed twice in PBS and then analysed microscopically and immunologically.
Reconstitution experiments with doublelabelled cells.-Murine or human tumour cells were labelled with 75Se-methionine (Bosslet et al., 1979) and murine splenic leucocytes (SL) or Ficoll-Hypaque-purified human peripheral-blood cells (PBC) (Boyum, 1968) with Na2 51CrO4 (Schirrmacher et al., 1979b) . After mixing of 5 x 106 755e-methionine-labelled tumour cells and 5 x 107 5ICr-labelled SL or PBC the mixture was separated in linear Percoll density gradients as described above, fractionated in 200,1/ portions, and the radioactivity distribution determined in a LKB Ultrogamma 1280-Counter set for twochannel analysis.
Cytotoxicity assay.-The separated tumourcell and host-cell bands were removed from the gradients with Pasteur pipettes, washed twice and assayed as described in Schirrmacher et al. (1979b) for the expression of surface markers in a 4h 5lCr-release assay.
RESULTS

Stability of buoyant density of tumour celllinesfrom culture
In an attempt to determine the buoyant density of tumour cells from culture, 6 different murine tumour-cell lines in stationary growth phase were compared with each other and with normal DBA/2 SL. It can be seen from the data in Table I that the tumour cells have a significantly lower buoyant density than the normal cells. In linear Percoll density gradients, tumour cells were found in bands ranging from 1-051 to 1-068 g/ml, whereas normal SL were found in bands ranging from 1-075 to 1-082 g/ml. Kerbel et al. (1978) . The data in Table I and II indicate that the buoyant density of murine and human tumour-cell lines from culture is a stable parameter. This stability was a prerequisite for the physical separation of tumour cells from normal cells.
Separation of 75Se-methionine-labelled tumour cells from 5 lCr-labelled normal cells Double-labelling experiments with tumour cells and normal cells were performed to determine the optimal conditions and the efficiency of the Percoll separation technique. Tumour cells were labelled internally with 75Se-methionine and SL with Na2 51CrO4. They were then mixed and centrifuged for 10 min at 2000 rev/ min in a linear preformed Percoll gradient (20-70%). Fractions were harvested from the top, and the radioactivity of each fraction measured in 2 channels set for optimal y emission energy of 75Se and 51Cr. Both figures show that the crosscontamination of the tumour cells with lymphocytes and vice versa is small (< 10%). Similar data were obtained with tumour cells admixed with normal cells from liver and lung tissue (data not shown). The recovery after the fractionation procedure varies between 60 and 80% of the input radioactivity. There is no significant change in the recovery if between 106 and 108 cells are admixed before the separation. Fig. 2 illustrates an experiment in which 5 x 107 human PBC separated from erythrocytes and granulocytes by FicollHypaque gradient centrifugation (Boyum, 1968) were labelled with 51Cr (A-A) and mixed with 75Se-methionine-labelled myeloma cells (L-Li) and centrifuged at equilibrium in a preformed linear Percoll gradient (70-20%). It can be seen that the human tumour cells could be separated only partially from the human peripheralblood mononuclear cells, which in this experiment had a density ranging from 1-40 to 1-060. There was an additional peak of peripheral-blood mononuclear cells at a density range from 1 080 to 1-085. These cells were clearly separtaed from the tumour cells. 4 6 * % 51Cr-release after 4h incubation of the 51Cr-labelled target cells with a 40-fold excess of specific cytotoxic T lymphocytes (CTL). These were directed either against the TATA (DBA/2 anti-ESB), against H-2k (BALB/c anti-CBA) or against H-2d (C57BL/6 anti-DBA/2) membrane antigens. In Table IV (Tables III and IV) .
The separation profiles of human peripheral-blood lymphocytes and human meyloma cells indicate that it is not possible under these conditions to isolate tumour cells completely free of normal mononuclear cells. The density range in which human peripheral-blood cells band in our gradients is slightly lower than that obtained by Pertoft et al. (1979 ), Gutierrez et al. (1979 and Ulmer & Flad (1979) , who used different centrifugation and Percolldilution protocols. We do not believe that these minor differences in density are due to the labelling procedure, because very similar density distributions were obtained with unlabelled PBC.
The method may have various practical applications in cancer research. Biological experiments in animal and human systems can use tumour cells freshly isolated and separated from the host, which has not been possible so far. The surfaces of these tumour cells can also be characterized by serological and biochemical procedures. This may help better to define the characteristics of metastatic and non-metastatic tumour cells. These advantages might render linear Percoll density gradients a useful tool in tumour immunology, especially in the relatively unexplored field of research into metastasis.
